Home Stock

Stock Research: Panion & Bf Biotech

Independent stock analysis through peer comparison: Get the 360° View as an objective basis for stock decision-making and explore the detailed ranks.

Panion & Bf Biotech

TAI:1760 TW0001760007
28
  • Value
    6
  • Growth
    51
  • Safety
    Safety
    55
  • Combined
    33
  • Sentiment
    45
  • 360° View
    360° View
    28
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

PANION & BF BIOTECH INC. manufactures and sells western medicines, experimental drugs, and cosmetics. The company also offers formula food, medical devices, animal and pet drugs, feed, and environmental health drugs, in addition to biotechnology services. It operates in the pharmaceuticals, cosmetics, and biotechnology industries. Its primary markets are Taiwan, mainland China, Hong Kong, and Macau. In the last fiscal year, the company had a market cap of $211 million, profits of $33 million, and revenue of $62 million. The number of employees is not available.

more

ANALYSIS: With an Obermatt 360° View of 28 (better than 28% compared with alternatives), overall professional sentiment and financial characteristics for the stock Panion & Bf Biotech are below the industry average. The 360° View is based on consolidating four consolidated indicators, with half of the metrics below and half above average for Panion & Bf Biotech. The consolidated Growth Rank has a good rank of 51, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. This means that growth is higher than for 51% of competitors in the same industry. In addition, the consolidated Safety Rank has a safer rank of 55 which means that the company has a financing structure that is safer than 55% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. But the consolidated Value Rank has a less desirable rank of 6 which means that the share price of Panion & Bf Biotech is on the higher side compared with typical size in indicators such as revenues, profits, and invested capital. This means that the stock price is higher than for 94% of alternative stocks in the same industry. The consolidated Sentiment Rank also has a low rank of 45, which means that professional investors are more pessimistic about the stock than for 55% of alternative investment opportunities. ...read more

more
Strongest Rank Analyst Opinions
Weakest Rank Liquidity
Country Taiwan
Industry Pharmaceuticals
Size Small
Website pbf.com.tw
Index
Panion & Bf Biotech stock price by TradingView. Not sourced by Obermatt.
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 3-Nov-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Value
Identifies how good a value the stock is.
Good Value Expensive
Combined
Consolidated view across Value, Growth, and Safety.
Good Tread Carefully
Growth
Shows a company's growth potential.
High Growth Tough Times
Sentiment
Shows what the market thinks of a stock.
Positive Sentiment Skepticism
Safety
Safety
Assesses how financially secure a company is.
Well-Financed High Leverage
360° View
360° View
Holistic stock analysis: all key non-/financial metrics
Good Watch Out

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for more than 8,000 stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
6 24 28 29
Growth
51 10 71 69
Safety
Safety
55 18 32 14
Sentiment
45 46 37 65
360° View
360° View
28 1 32 29
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for more than 8,000 stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
1 12 20 24
Opinions Change
50 50 50 50
Pro Holdings
n/a 28 24 90
Market Pulse
33 100 100 n/a
Sentiment
45 46 37 65
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for more than 8,000 stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
6 24 28 29
Growth
51 10 71 69
Safety Safety
55 18 32 14
Combined
33 1 37 24
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for more than 8,000 stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
27 26 22 31
Price vs. Earnings (P/E)
29 17 33 53
Price vs. Book (P/B)
19 17 16 20
Dividend Yield
1 52 57 33
Value
6 24 28 29
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for more than 8,000 stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
33 6 89 47
Profit Growth
53 18 59 7
Capital Growth
61 46 70 78
Stock Returns
47 36 9 81
Growth
51 10 71 69
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for more than 8,000 stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
54 30 43 1
Refinancing
20 11 17 13
Liquidity
82 28 67 39
Safety Safety
55 18 32 14

Similar Stocks

Discover high‑ranked alternatives to Panion & Bf Biotech and broaden your portfolio horizons.

Tokyo Century

TYO:8439
Country: Japan
Industry: Specialized Finance
Size: X-Large
Full Stock Analysis

Bridgestone

TYO:5108
Country: Japan
Industry: Tires & Rubber
Size: XX-Large
Full Stock Analysis

Omron

TYO:6645
Country: Japan
Industry: Electronic Components
Size: X-Large
Full Stock Analysis

Cosmo Energy Holdings

TYO:5021
Country: Japan
Industry: Oil & Gas Refining
Size: X-Large
Full Stock Analysis

Frequently Asked
Questions

The company has high growth and safe financing but is expensive (low Value Rank) and has low market sentiment. This is a warning that the stock may be too expensive. This is for an experienced growth investor willing to risk overpaying, but only after conducting thorough research on future growth potential.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

OTHER FEATURES

Use the Platform to its Fullest

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing:

Review us See More Google Reviews